Lopressor: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 21: | Line 21: | ||
===[[Lopressor pediatric indications and dosage#Off-Label Use and Dosage|Off-Label Use and Dosage (Pediatric)]]=== | ===[[Lopressor pediatric indications and dosage#Off-Label Use and Dosage|Off-Label Use and Dosage (Pediatric)]]=== | ||
==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]== | ==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]== | ||
Line 74: | Line 52: | ||
===[[Lopressor forms and administration#administration|Administration]]=== | ===[[Lopressor forms and administration#administration|Administration]]=== | ||
==[[Lopressor use in specific populations|Use in Specific Populations]]== | |||
===[[Lopressor dose adjustments#Pregnancy|Pregnancy]]=== | |||
===[[Lopressor dose adjustments#Labor and Delivery|Labor and Delivery]]=== | |||
===[[Lopressor dose adjustments#Nursing Mothers|Nursing Mothers]]=== | |||
===[[Lopressor dose adjustments#Pediatric Use|Pediatric Use]]=== | |||
===[[Lopressor dose adjustments#Geriatric Use|Geriatric Use]]=== | |||
===[[Lopressor dose adjustments#Gender|Gender]]=== | |||
===[[Lopressor dose adjustments#Race|Race]]=== | |||
===[[Lopressor dose adjustments#Renal Impairment|Renal Impairment]]=== | |||
===[[Lopressor dose adjustments#Hepatic Impairment|Hepatic Impairment]]=== | |||
===[[Lopressor dose adjustments#Females of Reproductive Potential and Males|Females of Reproductive Potential and Males]]=== | |||
===[[Lopressor dose adjustments#Immunocompromised Patients|Immunocompromised Patients]]=== | |||
Revision as of 17:44, 17 March 2014
Clinical data | |
---|---|
Trade names | Lopressor, Toprol-xl |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682864 |
[[Regulation of therapeutic goods |Template:Engvar data]] |
|
Pregnancy category | |
Routes of administration | Oral, IV |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 12% |
Metabolism | Hepatic via CYP2D6, CYP3A4 |
Elimination half-life | 3-7 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C15H25NO3 |
Molar mass | 267.364 g/mol |
3D model (JSmol) | |
Melting point | 120 °C (248 °F) |
| |
| |
(verify) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
For information about metoprolol, click here.
Disclaimer
Black Box Warning
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Off-Label Use and Dosage (Adult)
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Off-Label Use and Dosage (Pediatric)
FDA-Labeled Indications
Off-Label Use
Contraindications
Warnings and Precautions
Warnings
Precautions
Pregnancy Category
Drug Interactions
Adverse Reactions
Clinical Trials Experience
Postmarketing Experience
Mechanism of Action
Forms and Administration
Forms
Administration
Use in Specific Populations
Pregnancy
Labor and Delivery
Nursing Mothers
Pediatric Use
Geriatric Use
Gender
Race
Renal Impairment
Hepatic Impairment
Females of Reproductive Potential and Males
Immunocompromised Patients
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Price
Pill Images and Characteristics
Look-Alike Drug Names
IV compatibility
Categories:
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles with non-default infobox title
- Antianginals
- Antiarrhythmic agents
- Antihypertensive agents
- Antimigraine drugs
- Beta blockers
- Cardiovascular Drugs